SureTrader
Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

This a repost of mine from yahoo site

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
vorlon1966 Member Profile
 
Followed By 28
Posts 654
Boards Moderated 0
Alias Born 12/05/13
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/10/2016 6:12:04 AM
Provectus Biopharmaceuticals to Host Fourth Quarter, Year-End 2015 Conference Call Thursday, March 10, 2016, at 4 PM EST "Business Wire" - 2/10/2016 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/3/2016 6:08:51 AM
Data on Immunology Effects of Provectus Biopharmaceuticals PV-10 in Colon Cancer Presented at 11th Annual ASC Meeting "Business Wire" - 2/3/2016 6:00:00 AM
Provectus Biopharmaceuticals to Present at 18th Annual BIO CEO & Investor Conference "Business Wire" - 2/2/2016 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/22/2016 6:04:08 AM
Provectus Biopharmaceuticals Announces Immunology Data on PV-10 in Colon Cancer to Be Presented at 11th Annual ASC Meeting "Business Wire" - 1/22/2016 6:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 1/20/2016 4:17:45 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 1/19/2016 6:01:33 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) "Edgar (US Regulatory)" - 1/14/2016 4:16:58 PM
Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) "Edgar (US Regulatory)" - 1/14/2016 10:43:40 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/12/2016 6:07:12 AM
Provectus Biopharmaceuticals Confirms First Patients Dosed in Trials of PV-10 for Melanoma "Business Wire" - 1/12/2016 6:00:00 AM
Tender Offer Statement by Issuer (sc To-i) "Edgar (US Regulatory)" - 12/31/2015 4:26:40 PM
Securities Registration: Business Combination (s-4) "Edgar (US Regulatory)" - 12/31/2015 4:17:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/16/2015 6:05:18 AM
Provectus Biopharmaceuticals, Inc. to Present at Biotech Showcase™ 2016 on Wednesday January 13, 2016 at 3:30 PM Pacific Time "Business Wire" - 12/16/2015 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/10/2015 1:46:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/10/2015 1:41:14 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/10/2015 1:39:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/10/2015 1:37:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/10/2015 1:36:06 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/10/2015 1:32:48 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/10/2015 1:24:43 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/5/2015 5:02:50 PM
vorlon1966   Saturday, 12/28/13 12:08:00 PM
Re: buccaneer1961 post# 919
Post # of 7910 
This a repost of mine from yahoo site answering questions and comments.

They never failed
They shut down photogen to start pvct when they figured out they had a better product
They did get paid a few years a bunch.... They also are getting a product to market for around $130mm instead of $1.5 billion and in less time than normal.... We benefited from that because there are no partners to share in the end game... Probably would not be an end game otherwise....they would have taken over and you might have gotten a few bucks increase instead of the big payoff that's coming
They did not go for pIII right away when they realized they could invent a new synthesis for rb that can be approved internationally for oncology....99% purity
Patent awarded this year ....you have to go into pIII with the drug that gets approved...so they waited for the patent
PIII? No mention in 8k..... What was mentioned was btd and aa
Deliberate omission? Judge for yourself.
Large production runs done for Nda and ready to ship...hmmmmm.
Second Pfizer guy on advisory board with Chinese pharma experience
They have been working on a Chinese regional deal waiting on FDA clarity....hmmmmm
First Pfizer board member is an acquisition specialist.....hmmmmm
They changed their name and state of incorporation......around same time as FDA meeting.....hmmmmm
Pfizer losing patents on Lipitor and Viagra .....hmmmmm

You guys not getting this......???? hmmmmmm...

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist